These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3616951)

  • 1. [Comparative study of bile sedimentation rate and pH normally and in cholelithiasis patients].
    Mansurov KhKh; Dzhuraev KhSh; Mansurova FKh
    Ter Arkh; 1987; 59(5):87-91. PubMed ID: 3616951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of cholelithiasis].
    Mansurov KhKh
    Klin Med (Mosk); 1985 Jan; 63(1):10-6. PubMed ID: 2985865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dissolving of cholesterol gallstones. A current therapeutic problem].
    Erb W
    Med Klin; 1975 Jul; 70(28-29):1199-1207. PubMed ID: 1101004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug cholelitholysis and the nucleation time].
    Janowitz P; Swobodnik W; Wechsler JG; Fischer S; Ditschuneit H
    Dtsch Med Wochenschr; 1989 Jun; 114(25):983-5. PubMed ID: 2737092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 9. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 10. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
    Makino I; Yoneda M; Tamasawa N; Takebe K
    Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the therapeutic significance of ursodeoxycholic acid in the intravital dissolution of biliary calculi using chenodeoxycholic acid].
    Fromm H; Erbler HC; Eschler A; Schmidt FW
    Z Gastroenterol Verh; 1976; (9):37-9. PubMed ID: 64082
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment of cholelithiasis with chenodeoxycholic and ursodeoxycholic acid preparations].
    Golochevskaia VS; Genia LP
    Klin Med (Mosk); 1992; 70(7-8):60-3. PubMed ID: 1460833
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gallstone dissolution].
    Leuschner U
    Internist (Berl); 1980 Oct; 21(10):607-16. PubMed ID: 7005153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)].
    Hrabák P; Dosková M; Soucková E
    Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002
    [No Abstract]   [Full Text] [Related]  

  • 17. [New possibilities in the treatment of cholelithiasis].
    Genia LP; Grebenev AL
    Klin Med (Mosk); 1988 May; 66(5):30-7. PubMed ID: 3047491
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.